Alien DNA, retractions, whistleblowers & more: The wild saga of hydroxychloroquine | New benefits of evolocumab

Hydroxychloroquine was once just an ordinary antimalarial medication—and then 2020 and COVID-19 happened. So how did we get here? 

Overall, the PCSK9 inhibitor was associated with a steady increase in coronary artery area and “significant coronary blood flow improvement.”

In this modern era of healthcare where value trumps volume, assessing a physician’s performance is more important than ever.

Nearly 600 hospitals were considered for this updated ranking. 

Consolidation has been a major theme for healthcare providers in recent years, with larger practices continuing to thrive compared to their smaller counterparts. But what about cardiology specifically? 

Cardiac involvement and myocardial inflammation are common in recovered COVID-19 patients, according to a new study published in JAMA Cardiology.

The authors tracked more than 108,000 patients who suffered their first heart attack between 2009 and 2013.

That risk only grew for those with underlying hypertension, suggesting women between 30 and 60 years old may benefit from screening, researchers wrote recently.

Mid-Delaware Imaging said it first became aware of the incident earlier this year, with leaders recently notifying the FBI.